Rosebud Biosciences YC Application

Winter 2022Active

Rosebud Biosciences went through Y Combinator in the Winter 2022 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Winter 2022
Industry: HealthcareDrug Discovery and Delivery
Team size: 3
Status: Active
Launched: 2022

Founders

Kitch WilsonFounder
Evan LyallFounder

What Rosebud Biosciences does

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

Rosebud Biosciences's YC application, reconstructed

Y Combinator application

Rosebud Biosciences, Winter 2022 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Rosebud Biosciences

Describe what your company does in 50 characters or less.

Growing micro-organs to find new drugs

What is your company going to make? Please describe your product and what it does or will do.

We grow organoids with the patients' exact gene mutations to test drugs directly on tissue models that behave like fetal organs. Our platform lets us screen drugs for rare diseases, especially pediatric conditions without treatments. It helps partners find drug candidates faster by using more accurate disease models than standard cell lines or animal models.

Where do you live now, and where would the company be based after YC?

We're based in San Francisco and San Carlos, CA. After YC, we'll stay in the Bay Area to stay close to collaborators and biotech talent.

Explain your decision regarding location.

We want to be near key research institutions and pharma partners, and both of us are already based in the Bay Area. It's where organoid research and biotech venture capital mix best.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Rosebud Biosciences YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Rosebud Biosciences's public data (launch notes, founder backgrounds, product description). It shows how a company like Rosebud Biosciences would present itself to YC, not the text they submitted.